Financial Data and Key Metrics Changes - The company reported full year organic sales growth of 2%, operating EBITDA growth of 6%, and adjusted EPS of $1.68 per share, up 16% year-over-year [5][6][12] - Free cash flow generation was strong, with expectations for 2026 to exceed 90% conversion [12][21] Business Line Data and Key Metrics Changes - Healthcare and water technologies saw fourth quarter net sales of $821 million, up 4% year-over-year, driven by 3% organic growth [17] - Diversified industrials reported fourth quarter net sales of $872 million, a 3% decrease year-over-year, with a 4% organic decline [18] Market Data and Key Metrics Changes - Organic growth in Europe was up 2% year-over-year, while Asia-Pacific was down 2% [16] - The automotive market is expected to remain flat in 2026, with electric vehicle builds anticipated to outpace overall builds [12][71] Company Strategy and Development Direction - The company aims to drive above-market organic growth and deploy a balanced capital allocation model while enhancing core values and operational excellence [8][11] - The strategic priorities for 2026 include launching over 125 new products, which generated more than $2 billion in sales [8][57] Management's Comments on Operating Environment and Future Outlook - Management noted a mixed macro environment, with healthcare and water technologies expected to grow mid-single digits, while automotive demand is flat [12][13] - The company is optimistic about order trends in industrial technologies, indicating a stabilization and recovery in those markets [14] Other Important Information - The company completed the separation of QUNITY Electronics and is focused on operational and portfolio transformation [6][7] - A $2 billion share repurchase authorization was announced, with $500 million executed in the fourth quarter of 2025 [11][49] Q&A Session Summary Question: Insights on industrial production trends - Management indicated that industrial orders are picking up, particularly in aerospace, with low double-digit improvements noted [31] Question: Pricing and inflation outlook - The company expects no significant headwinds from inflation and anticipates improvements in gross margins due to productivity initiatives [32] Question: Shelter business outlook - The shelter business is expected to start slightly down but improve throughout the year, aiming for flat performance overall [39] Question: Vitality Index context - The Vitality Index of 30% reflects a mix of replacement and growth, with efforts to shift towards more growth-oriented products [41][43] Question: Margin improvements in diversified industrials - Margin expansion was driven by favorable mix and productivity, with benefits from ongoing initiatives expected in the future [55] Question: M&A opportunities - The company is actively scouting M&A opportunities, particularly in healthcare, to enhance its portfolio [50][105] Question: Water business growth in China - Slower growth in China is attributed to reduced industrial production, but the company expects to ramp up in the latter half of the year [66] Question: Overall cash management and capital allocation - The company aims to maintain around $1 billion in cash and will deploy capital based on shareholder value, balancing M&A and share repurchases [89]

DuPont De Nemours (NYSE:DD) Q4 2025 Earnings call February 10, 2026 08:00 AM ET Speaker9Ladies and gentlemen, thank you for standing by. My name is Krista, and I will be your conference operator today. At this time, I would like to welcome you to DuPont's fourth quarter and full year 2025 earnings conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. If you would like to ask a question at that time, simp ...